Vaccines a health victory and excellent buy
Indian medicine going global?
AAP updates policy on off-label drug use in children
Improving antibiotic prescribing results in safer healthcare
Primary care in England heading towards a crisis
Ankylosing spondylitis costly in South Korea
Very few Americans know about the ACA's provisions
Analysing biosimilar G-CSF markets in 5 EU countries
Cataract surgery, RE correction highly cost effective in Zambia
Diabetes-related complications costly in the US
Guidelines on use of dronedarone in AF questioned
Final results of ORAR 3 favour oral rapamycin plus BMS
England's CDF used to access non-cost effective drugs
HeartWare beats HeartMate II, but choice still not clear
Hospital costs for congenital heart surgery vary widely across US
Is SBP reduction in mild hypertension cost effective?
Individualised medicine neither more nor less cost effective
Qatar pharmacists support use of generics
Pay-for-performance improves antibiotic prescribing practices
Quantifying the impact of adolescent peer status
LNG-IUS more effective contraceptive at lower cost
Rotavirus vaccination not yet cost saving in Germany
Switching to biologics for psoriasis pays off in Italy
Ranolazine added to anti-anginals good value for money
VEGF inhibitor + laser therapy preferred option in DMO
The elephant in the room: the high cost of progress in oncology
New diabetes, glaucoma, and sarcoma drugs listed by PBS
Insurers and Medicaid fear big hepatitis C drug bill
New EU rules on funding of reinforced pharmacovigilance
Australia's PBPA to cease operations
NICE recommends aflibercept for macular oedema …
Rate of sickness absence falls in the UK
Novaris and Roche fined in Italy over collusion on Avastin
Partnership ensures access to affordable inactivated polio vax